Dr. Eman Shalaby, National research centre, Egypt
Eman Samy Ibrahim Shalaby ๐, an accomplished researcher in pharmaceutical technology, holds a Ph.D. in Industrial Pharmacy (2020) from Cairo University, specializing in nanostructured lipid carriers for folic acid delivery. With over a decade of experience at the National Research Center (NRC) ๐ข, she progressed from Specialist (2011โ2015) to Researcher (2020โPresent). Eman actively contributes to cutting-edge nanotechnology-based drug delivery systems ๐ and has presented her findings at renowned conferences worldwide ๐. Passionate about advancing pharmaceutical sciences, she has also delivered workshops on scientific publishing, grant writing, and stability studies ๐.
Professional Profile:
Orcid
Scopus
Summary of Suitability for the Women Researcher Award
Eman Samy Ibrahim Shalaby is a highly deserving candidate for the Women Researcher Award due to her impactful contributions to pharmaceutical technology and nanotechnology-based drug delivery systems.
Education & Experience
๐ Education
- Ph.D. in Industrial Pharmacy | Cairo University (2020)
- M.Sc. in Pharmaceutical Industry | Cairo University (2014)
- Thesis: Novel Nanodelivery System for Topical Folic Acid
- B.Pharm | Cairo University (2009)
๐งโ๐ฌ Experience
- Researcher | Department of Pharmaceutical Technology, NRC (2020โPresent)
- Research Assistant | NRC (2015โ2020)
- Specialist | NRC (2011โ2015)
Professional Development
Eman Samy Ibrahim Shalaby has actively enriched her expertise through global workshops and webinars ๐. She has delivered lectures on stability studies, manuscript writing โ๏ธ, and hair treatments ๐โโ๏ธ. Her professional journey includes participating in webinars by Elsevier and BRSF on scientific publishing ๐, grant funding ๐ผ, and advanced pharmaceutical applications. She played a key role in international forums on COVID-19 research, healthcare, and nutrition ๐, ensuring her contributions align with current scientific and societal needs ๐ฑ. Emanโs commitment to innovation and professional growth drives her impactful presence in pharmaceutical research ๐งช.
Research Focus
Eman specializes in nanotechnology-based drug delivery systems ๐, focusing on enhancing therapeutic outcomes through advanced delivery methods. Her Ph.D. research explored the formulation and characterization of nanostructured lipid carriers (NLCs) for folic acid delivery ๐งฌ, addressing bioavailability and targeted performance. Emanโs work bridges pharmaceutical nanotechnology and biological sciences, exploring innovative solutions for topical and systemic treatments ๐ฉบ. She actively contributes to research aimed at combating health challenges such as cancer, nutritional deficiencies, and novel therapies ๐. Her research demonstrates a commitment to advancing precision medicine through cutting-edge nanotechnology solutions ๐ฌ.
Awards & Honors
๐ Speaker Awards at International Conferences:
- 7th International Conference of Pharmaceutical and Drug Industries Research Institute (2023)
- 2nd International Conference in Nanotechnology, Biotechnology, Spectroscopy (2013)
๐ Participation Honors:
- Recognized at the Cairo Science Forum: Science and Research Diplomacy for Climate Action (2023)
- Notable attendee of the International Conference on Cancer Treatment and Diagnosis (2023)
โ๏ธ Workshop Contributions: Delivered sessions on scientific publishing, proposal writing, and nanotechnology-based applications.
Publication Top Notes:
-
Comparative study of niosomes and spanlastics as a promising approach for enhancing benzalkonium chloride topical wound healing: In-vitro and in-vivo studies
-
Chitosan tamarind-based nanoparticles as a promising approach for topical application of curcumin intended for burn healing: in vitro and in vivo study
-
Optimization of folic acid Span 60-organogel to enhance its in vitro and in vivo photoprotection: a comparative study
-
Development of folic acidโloaded nanostructured lipid carriers for topical delivery: preparation, characterisation and ex vivo investigation
-
Comparative study for optimization of folic acid nanoparticles